FDA has leaned toward requiring more PMAs than 510(k)s for preamendment medical devices since it launched its focused risk classification effort in 2009. Although there have been some complaints, stakeholders generally say the agency has taken an even-handed approach to revising regulatory requirements under its “515 program initiative.”
“I think they’re using an appropriate risk-based, scientific approach, where they’re analyzing each device very carefully and making the appropriate recommendation, based on their analysis,” said Josh Rising, director of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?